(XYL) Xylem Inc. Company Overview

US | Industrials | Industrial - Machinery | NYSE

(XYL) Xylem Inc. Bundle

Get Full Bundle:
$9 $5
$9 $5
$9 $5
$19 $9
$9 $5
$9 $5
$9 $5
$9 $5
$9 $5

TOTAL:

What does Xylem do across the global water cycle?

Xylem Inc. is a New York Stock Exchange-listed water technology company whose portfolio spans the movement, treatment, measurement, analysis, reuse and servicing of water. In plain English, it sells the equipment and expertise that utilities, factories, commercial buildings and infrastructure operators need to make water systems work. The company is not a municipal utility and does not generally earn regulated returns from owning water networks. It earns revenue by supplying pumps, treatment systems, smart meters, sensors, software, project equipment, rentals and recurring field services to the organizations that own or operate those networks.

The 2025 Form 10-K organizes the business into four reportable segments. That structure matters because each segment has a different mix of product revenue, service intensity, channel economics and project risk.

Identity item Company-specific answer Analytical implication
Official name and ticker Xylem Inc. (NYSE: XYL) One common share class trades with one vote per share.
Core market Water technology, equipment, digital measurement and services Demand is tied to infrastructure renewal, industrial production, regulation and water scarcity rather than one consumer cycle.
Customer groups Utilities, industrial plants, commercial buildings, original equipment manufacturers and public-sector operators No single customer represented more than 5% of consolidated revenue in FY2025.
FY2025 scale $9.035B revenue Scale supports global procurement, channel reach, installed-base service and portfolio breadth.

Which operating segments define the company?

Water Infrastructure
$2.636B
FY2025 revenue from transport and treatment systems, including pumps, filtration, disinfection and biological treatment.
Applied Water
$1.849B
FY2025 revenue from building solutions and industrial-water products sold largely through specialized distribution channels.
Measurement and Control Solutions
$2.086B
FY2025 revenue from smart metering, communications, analytics, instruments, sensors and managed services.
Water Solutions and Services
$2.464B
FY2025 revenue from outsourced water, treatment projects, rentals, dewatering, emergency response and recurring services.

Where does Xylem sell?

Xylem is geographically broad but economically concentrated in developed infrastructure markets. In FY2025, the United States generated 58% of revenue, Western Europe 20%, emerging markets 14% and other markets 8%. That mix gives the company exposure to long-duration utility and industrial spending, but it also makes U.S. public investment, European industrial conditions, currency translation and global trade rules meaningful variables.

Geographic revenue mix — FY2025
United States — 58% ($5.209B)
Western Europe — 20% ($1.839B)
Emerging markets — 14% ($1.221B)
Other — 8% ($766M)
Takeaway: U.S. demand is the largest geographic driver, but nearly half of revenue still depends on international markets and currency movements.

How does Xylem make money, and which segment matters most?

Xylem’s business model combines three economic layers. First, it sells engineered equipment such as pumps, meters, treatment units and analytical instruments. Second, it earns project and systems revenue when it integrates equipment into a customer’s site or network. Third, it monetizes the installed base through maintenance, rentals, testing, remote monitoring, managed services, replacement parts and outsourced water operations. The blend is important: product sales create the installed base, while service and digital relationships can deepen customer retention and improve revenue visibility.

Revenue by reportable segment — FY2025
$9.035B
Water Infrastructure — 29.2% ($2.636B)
Water Solutions and Services — 27.2% ($2.464B)
Measurement and Control Solutions — 23.1% ($2.086B)
Applied Water — 20.5% ($1.849B)
Takeaway: no segment exceeds 30% of FY2025 revenue, reducing single-division dependence while increasing portfolio-management complexity.

What are the segment revenue engines?

Segment FY2025 revenue Primary revenue logic Margin and growth driver
Water Infrastructure $2.636B Engineered transport and treatment equipment sold directly, through distributors and with service support. Project execution, mix, price realization, productivity and municipal or industrial capital spending.
Applied Water $1.849B Pumps, valves, heat exchangers and controls for buildings and industrial applications. Distributor demand, construction and industrial cycles, product mix and channel inventory.
Measurement and Control Solutions $2.086B Smart meters, communications, analytics, instruments, software and managed services. Utility modernization, backlog conversion, semiconductor availability, software mix and installed network expansion.
Water Solutions and Services $2.464B Treatment projects, outsourced water, rentals, dewatering and branch-based services. Utilization, contract execution, service density, lifecycle relationships and integration benefits from Evoqua.

How does the installed base become recurring cash flow?

Step 1
Win the specification
Application engineers help utilities or industrial customers select equipment for a mission-critical water process.
Step 2
Install equipment and systems
Pumps, meters, treatment assets and controls create a long-lived installed base.
Step 3
Add data and monitoring
Connected meters, sensors and analytics raise visibility into performance, leakage, quality and asset condition.
Step 4
Provide lifecycle service
Maintenance, parts, rentals, field support and outsourced operations extend the customer relationship.

What did Xylem’s first quarter of 2026 show?

The quarter ended March 31, 2026 showed a company with modest organic demand but improving earnings quality. According to the first-quarter earnings release, reported revenue increased 3% to $2.125 billion, while organic revenue was flat. Currency provided much of the reported growth. Even so, reported operating income rose, net income expanded and operating cash flow improved sharply from the prior-year quarter.

$2.125B
Q1 2026 revenue; up 3% reported and flat organically
$244M
Q1 2026 operating income; 11.5% reported margin
$193M
Q1 2026 net income attributable to Xylem; 9.1% margin
$1.12
Q1 2026 adjusted diluted EPS; up 9% year over year

How did the latest period compare with Q1 2025?

Metric Q1 2026 Q1 2025 Interpretation
Revenue $2.125B $2.069B Reportedgrowth was positive, but organic growth was approximately flat.
Gross profit $803M $768M Gross margin was approximately 37.8% in Q1 2026 versus 37.1% in Q1 2025.
Operating income $244M $231M Reported operating margin improved to 11.5% from 11.2%.
Operating cash flow $108M $33M Working-capital and payment timing produced a much stronger start to cash generation.
Capital expenditures $90M $71M Simple free cash flow was about $18M in Q1 2026, calculated as operating cash flow less capex.

Which segment signals were strongest and weakest?

The Q1 2026 Form 10-Q shows divergent segment economics. Water Solutions and Services reported only 0.5% revenue growth, yet operating income rose 27.3% and margin expanded to 9.9%. Measurement and Control Solutions produced the strongest order growth, with orders up 18% reported and 15% organically, but its reported operating margin slipped to 11.2%. Water Infrastructure revenue rose 4%, while Applied Water revenue rose 3%.

Q1 2026 segment revenue, ranked by size
Water Infrastructure $603M
Water Solutions and Services $566M
Measurement and Control Solutions $508M
Applied Water $448M
Takeaway: revenue remained balanced, while profitability improvement was most visible in Water Solutions and Services. Period: Q1 2026.

Orders of $2.228 billion produced a 105% book-to-bill ratio, and backlog ended the quarter at $4.712 billion. Backlog was 7.5% below March 2025 because revenue conversion and improved lead times outpaced new intake in some businesses, but it was 2.1% above December 2025. For analysts, that combination suggests normalization rather than a simple demand collapse: the timing, mix and conversion of backlog matter as much as the headline balance.

What turning points shaped Xylem’s current strategy?

Xylem’s history is best understood as a migration from a diversified equipment portfolio toward a broader water-solutions platform. The company began as a standalone public business after its 2011 separation from ITT. Since then, acquisitions and organizational changes have added smart metering, infrastructure diagnostics, digital analytics, outsourced treatment and service density. Those choices explain why the company now reports four segments rather than presenting itself as a pump manufacturer.

  1. 2011
    Xylem completed its spin-off from ITT and began trading independently. The separation created a focused water-technology company with a dedicated capital-allocation strategy.
  2. 2016
    The company acquired Sensus for approximately $1.7 billion, adding smart meters, licensed-spectrum communications and analytics. This was the decisive move toward connected infrastructure.
  3. 2018
    Pure Technologies and related analytics assets strengthened pipeline assessment and condition-monitoring capabilities, extending Xylem from equipment into infrastructure intelligence.
  4. 2023
    Xylem completed the Evoqua acquisition, creating a larger treatment and services platform with deeper industrial exposure and a broader installed service network.
  5. 2024
    Matthew Pine became CEO, and Xylem formed the Water Solutions and Services segment to combine legacy Evoqua services with dewatering and assessment operations.
  6. 2025–2026
    Management emphasized portfolio simplification, productivity and profitable growth, while restructuring actions continued through 2026 to improve the post-acquisition operating model.

Why was Sensus strategically important?

The Sensus transaction added a digital layer to Xylem’s physical water assets. Smart meters and communications networks create data about usage, leaks and asset performance. Once embedded in a utility network, those systems can be costly and operationally risky to replace, which can increase switching costs and support follow-on software, service and replacement demand.

What did the Evoqua combination change?

The Evoqua acquisition broadened Xylem’s industrial treatment, outsourced-water and service capabilities. It also increased goodwill and intangible assets, making integration execution and return on invested capital more important. Strategically, the deal shifted the company closer to a lifecycle model: design or install a treatment solution, operate or service it, then retain the relationship through maintenance, consumables, rentals and upgrades.

The central strategic shift is from selling water equipment to owning more of the customer’s water-management problem over the asset’s life.

What gives Xylem a competitive advantage in water technology?

Xylem’s moat is not one patent, one brand or one regulated franchise. It is a system of accumulated advantages: application know-how, installed equipment, recognized brands, utility relationships, distribution channels, service branches, connected-device data and a portfolio that spans multiple stages of the water cycle. The company’s own purpose and values materials frame the strategy around building a more water-secure world; commercially, that purpose matters when it aligns product development with customer problems such as leakage, contamination, resilience and energy use.

Where are switching costs and customer trust strongest?

Installed-base and replacement demand Strong
Application engineering and reliability Strong
Digital network switching costs Strong
Recurring service density Developing
Pricing power across the full portfolio Moderate

Reliability matters because water assets are often mission-critical and costly to shut down. A utility replacing a smart-meter network, a factory changing ultrapure-water equipment or a municipality selecting wastewater pumps evaluates lifecycle performance, integration risk, service response and regulatory compliance—not only the initial price. That decision process favors suppliers with references, local support and a large installed base.

Who are Xylem’s main competitors?

The water market is fragmented, and no single competitor matches Xylem across every application. Competitive pressure changes by product: pump and flow-control specialists compete in transport; diversified treatment companies compete in industrial and municipal systems; metering firms compete in utility measurement; and local engineering or service companies compete for projects and maintenance. Representative public-company rivals include Pentair, Ecolab, Badger Meter, Itron and Veolia, while privately held specialists such as Grundfos and KSB are important in selected equipment categories.

Competitive arena Representative rivals Xylem differentiator Pressure point
Pumps and flow equipment Grundfos, KSB, Pentair and regional manufacturers Broad installed base, wastewater expertise, energy efficiency and application engineering. Price competition and distributor bargaining power in standardized products.
Industrial and municipal treatment Ecolab, Veolia and specialist integrators Combination of equipment, treatment processes, rentals and lifecycle service. Project execution, performance guarantees and customer capital budgets.
Smart metering and utility networks Itron, Badger Meter and communications specialists Sensus installed base, FlexNet communications and integration with broader water analytics. Technology cycles, cybersecurity and utility procurement timing.
Services and outsourced water Local contractors, engineering firms and treatment service providers Global service branches, rental assets and cross-selling into existing industrial accounts. Labor intensity, utilization and local execution quality.

How financially strong is Xylem after the Evoqua integration?

FY2025 demonstrated meaningful operating leverage. Revenue increased 5.5% to $9.035 billion, but operating income rose 21.2% to $1.223 billion. Reported operating margin expanded from 11.8% to 13.5%, while adjusted operating margin reached 17.8%. The gap between reported and adjusted profit is still important because amortization, restructuring, divestiture and integration items are real economic consequences of portfolio change even when management excludes them from adjusted results.

Revenue progression — FY2023 to FY2025
$7.364B FY2023
$8.562B FY2024
$9.035B FY2025
Takeaway: the Evoqua combination increased scale, while FY2025 growth became primarily organic rather than acquisition-driven.

How strong are margins and cash conversion?

FY2025 profitability
13.5% operating margin
Up 170 basis points from FY2024 as productivity, price and integration benefits outpaced cost pressure.
FY2025 cash generation
$910M free cash flow
Calculated by Xylem as $1.241B operating cash flow less $331M capital expenditures.
38.5%
FY2025 reported gross margin. The green arc represents gross profit as a percentage of revenue; margin increased from 37.5% in FY2024.

Cash conversion was solid but not perfect. Free cash flow declined 3% in FY2025 despite higher earnings because the company spent more on long-term outsourced-water projects, strategic investments and restructuring, while customer advances and deferred revenue normalized. This is a useful warning for DCF work: accounting margin expansion does not automatically produce equal free-cash-flow growth when working capital and project investment absorb cash.

What does the balance sheet say about resilience?

At December 31, 2025, Xylem held $1.479 billion of cash and $1.942 billion of total debt. By March 31, 2026, cash had fallen to $808 million after $563 million of share repurchases and $106 million of dividends in the quarter, while short- and long-term debt totaled approximately $1.938 billion. Liquidity remains supported by operating cash flow and capital-market access, but the balance sheet also contains $8.292 billion of goodwill and $2.213 billion of other intangible assets at Q1 2026. Those acquisition-related assets make sustained segment cash flows and impairment discipline important.

How does capital allocation affect the Xylem story?

Capital allocation has shifted from acquisition funding toward integration, internal investment and shareholder returns. The Evoqua transaction materially expanded goodwill, services capacity and industrial exposure; the next phase is proving that the combined platform can generate higher margins and cash returns. Management must balance five uses of cash: organic capex, research and development, restructuring or simplification, dividends, and opportunistic repurchases or acquisitions.

Where did cash go in FY2025 and Q1 2026?

Capital-allocation item Official period and amount What it signals
Research and development FY2025: $226M Continued investment in product efficiency, controls, digital measurement and treatment technology.
Capital expenditures FY2025: $331M Supports factories, software, service infrastructure, rental assets and growth projects.
Dividends paid FY2025: $391M A recurring cash commitment; dividends per share paid increased 11% in FY2025.
Share repurchases Q1 2026: $563M A large acceleration versus FY2025, reducing cash and making valuation discipline relevant.
Restructuring and impairment charges FY2025: $103M Evidence that simplification carries near-term costs before savings are fully realized.
$49M of expected costs remained at December 31, 2025 for restructuring actions begun in 2025; management indicated those actions would continue through the end of 2026.

The key question is not whether Xylem can fund its program, but whether each dollar earns an adequate return. Investors should compare margin gains and free-cash-flow growth with the cumulative cost of acquisitions, restructuring, intangible amortization and repurchases. A company can report strong adjusted EPS while still destroying value if acquisition synergies disappoint or buybacks occur at unattractive prices.

Who owns Xylem stock, and how is governance structured?

Xylem has a conventional one-share, one-vote structure rather than founder control or dual-class voting. The investor base is therefore institutionally influenced. The 2026 proxy statement identifies Vanguard and BlackRock as the only disclosed holders above 5%, while directors and executive officers as a group own less than 1%. That pattern means governance pressure is likely to focus on execution, capital allocation, board oversight and compensation design rather than a controlling shareholder’s strategic agenda.

Which holders have the largest disclosed economic stakes?

Holder or group Shares disclosed Percent of class Why it matters
The Vanguard Group 28,047,688 11.5% Large passive ownership amplifies the importance of governance standards and long-term capital discipline.
BlackRock, Inc. 24,255,217 10.0% Another large institutional block with voting influence but no operating control.
CEO Matthew Pine 299,154 Less than 1% Personal ownership aligns management with shareholders, but does not create founder-style control.
Directors and executive officers as a group 786,605 Less than 1% Influence comes through roles, incentives and board authority rather than a large economic block.

What governance signals should researchers notice?

Board independence
8 of 9
Current directors were classified as independent in the 2026 proxy; the CEO was the only non-independent director.
Leadership structure
Independent chair
The separate chair role strengthens formal oversight of strategy, succession, risk and CEO evaluation.
CEO ownership guideline
6× salary
The guideline is designed to align executives with long-term shareholder value and discourage short-term risk taking.
Average nominee tenure
7.3 years
The board combines institutional knowledge with a stated refreshment process.

What opportunities and risks could change Xylem’s outlook?

The long-run opportunity is supported by structural water problems: aging infrastructure, leakage, water scarcity, contaminants, stricter treatment requirements, industrial reuse and the need to reduce the energy consumed by pumps and treatment systems. These forces can support demand even when general industrial growth is moderate. Xylem’s 2024 investor-day strategy emphasized above-market growth, margin expansion and simplification; the current test is whether the company can translate those themes into durable organic orders, higher service density and cash returns.

Where are the most credible growth avenues?

Lower execution complexityHigher execution complexity
High strategic fit / Lower complexity
Cross-selling treatment, meters, analytics and service into existing utility and industrial accounts. This uses the installed base without requiring another transformational acquisition.
High strategic fit / Higher complexity
Scaling outsourced water, reuse and large treatment projects. These can deepen customer relationships but require project execution, working capital and operating discipline.
Moderate fit / Lower complexity
Incremental product pricing, portfolio simplification and productivity. These levers can lift margins even when organic volume is subdued.
Moderate fit / Higher complexity
Large new acquisitions. They may add capabilities, but goodwill, integration cost and capital-allocation risk are already material after Evoqua.

Management raised its 2026 reported revenue outlook after Q1 to approximately $9.2 billion to $9.3 billion, while maintaining organic growth guidance of 2% to 4%. It also expected adjusted EBITDA margin of 22.9% to 23.3%, adjusted EPS of $5.35 to $5.60 and free-cash-flow margin of 10.2% to 11.0%. Those targets imply that productivity and mix must do significant work if volume growth remains moderate.

Which risks deserve the closest monitoring?

The risk section of Xylem’s filings is broad, but several items connect directly to the economics of the business. Large projects can carry performance guarantees and timeline risk. Connected products create cybersecurity and data-privacy exposure. Manufacturing depends on semiconductors, electronic components, metals and global suppliers. Tariffs and currency movements can alter cost and reported growth. Environmental, safety and product-quality obligations can create warranty, recall or legal costs. Finally, goodwill and intangible assets could be impaired if acquired businesses underperform.

Organic orders growth
Q1 2026 was flat company-wide; sustained improvement would support future revenue beyond currency effects.
Backlog conversion and renewal
Monitor whether the $4.712B Q1 2026 backlog converts without weakening future order coverage.
Water Solutions and Services margin
The Q1 2026 margin reached 9.9%; further expansion would validate service integration and productivity.
Measurement and Control orders
Organic orders rose 15% in Q1 2026, making future smart-meter and network revenue conversion a key signal.
Free-cash-flow margin
The 2026 target is 10.2% to 11.0%; working capital and outsourced-water investment can create volatility.
Restructuring savings versus charges
Track whether simplification produces recurring margin gains after the remaining 2025-plan costs are incurred.
Cybersecurity and connected-product reliability
A larger digital installed base strengthens switching costs but increases the potential impact of a network or data incident.
Goodwill and intangible returns
Acquisition assets are large; weak cash flows in a reporting unit could trigger impairment and question deal economics.

What is the key takeaway from Xylem analysis?

Xylem matters because it has assembled one of the broadest public-company platforms focused specifically on water. Its portfolio connects physical infrastructure, treatment, measurement, analytics and services, while its customer base is diversified and its end markets benefit from long-term needs that cannot be deferred forever. The strategic case is strongest where equipment, data and lifecycle service reinforce one another and create switching costs around mission-critical operations.

Which DCF assumptions matter most?

Revenue growth
Organic, not reported
Separate underlying volume and price from acquisitions, divestitures and currency. Q1 2026 reported growth exceeded organic growth.
Operating margin
Productivity versus mix
A credible model should test whether FY2025 margin gains persist after restructuring and integration benefits mature.
Reinvestment
Capex plus working capital
Service, rental and outsourced-water growth may consume cash beyond conventional factory capex.
Terminal risk
Moat versus project risk
Installed-base advantages support durability, but competition, technology, execution and impairment risk limit overly aggressive assumptions.

The current tension is clear: Xylem has strong structural demand and improving profitability, but near-term organic growth is moderate and the post-Evoqua platform still has to prove consistent free-cash-flow conversion. Students can extract a classic strategy case from this balance. The strengths are portfolio breadth, application expertise, installed-base relationships and exposure to essential infrastructure. The weaknesses are complexity, acquisition-related assets and uneven segment margins. Opportunities come from digital water, reuse, service cross-selling and regulation-driven investment. Threats include project failures, supply or tariff pressure, cybersecurity, industrial cyclicality and unsuccessful capital allocation.

Final synthesis
Xylem’s investment and research story is not simply “water demand will grow.” It is whether the company can convert a broad water-technology portfolio into sustained organic orders, higher service intensity, expanding margins and free cash flow—without allowing integration costs, project risk, digital vulnerabilities or expensive capital allocation to dilute the advantage.

DCF model

    5-Year Financial Model

    40+ Charts & Metrics

    DCF & Multiple Valuation

    Free Email Support



Disclaimer

All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.

We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.

All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.